El VHIO lidera en Europa un nuevo concepto de estudio que integra ensayos clínicos basket en oncología

by VHIO

El estudio, diseñado por el Dr. Jordi Rodón y la Dra. Irene Braña, se centra en las características moleculares de los tumores, pudiendo agrupar en un mismo módulo o basket pacientes con tumores ...

Read more

Iproteos, IBEC and VHIR to develop an innovative therapy against solid tumors

by Vall d’Hebron

The project, which received €935,000 in MINECO’s 2017 Retos Colaboración call, will focus in its first phase on two of the most common solid tumors in children and adolescents, rhabdomyosarcoma a...

Read more

El VHIR amplía su equipo implicándose en proyectos contra la tuberculosis y el Chagas

by Vall d’Hebron

eSPiC nació en 1994, con la intención de conseguir una atención sanitaria equitativa, integral y sostenible. Se encuentra en la Unidad de Salud Internacional Drassanes del Institut Català de la Sa...

Read more

Probitas and VHIR sign two cooperation agreements in the field of International Health

by Vall d’Hebron

The agreement will allow Probitas Foundation, which develops its projects in the most vulnerable areas of the world, and the research group in Microbiology of VHIR to work together to improve access o...

Read more

The second Scientific Retreat brings VHIR researchers and support units closer together

by Vall d’Hebron

On 11 and 12 November took place the second Scientific Retreat at Vall d'Hebron Research Institute (VHIR). The gathering took place in Cardona, and for two days, the principal investigators and the he...

Read more

The European Congress of Paediatric Orthopaedic awards a VHIR’s research

by Vall d’Hebron

The European Paediatric Orthopaedic Society has awarded the prize Predrag Klisic for basic research to a study by the Vall d'Hebron Research Institute (VHIR) on the bone antibiotic bioavailability in ...

Read more

Barcelona Health Hub

by BioVentures Investors

El ecosistema de ciencias de la vida y salud de Barcelona está articulado en torno a un potente núcleo formado por hospitales públicos, compañías farmacéuticas y centros de investigación. No ob...

Read more

VHIR: The Infectious Diseases group has been awarded for a project that seeks new strategies to treat antimicrobial resistant infections

by Vall d’Hebron

Dr. Gavaldà comments “Access to effective antibiotics is essential in all health systems. Their use has reduced childhood mortality and increased life expectancy, and they are crucial for invasive ...

Read more

International collaboration between VHIR and UAB for Cerebral Infarction treatment

by Vall d’Hebron

Going forward, they will proceed with the development of RTU-009 as acombinationwith t-PA treatment for acute cerebral infarction as the top priority target

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Apposite Capital refuerza su apuesta por...

by NIMGenetics

La firma británica se convierte en accionista mayoritario de la empre...

Photos Stream